Sensus Healthcare Takes Order for 10 TransDermal Infusion Systems™ Supporting Hair Enhancement … | News

BOCA RATON, Fla., July 27, 2022 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical gadget firm specializing in extremely efficient, non-invasive, minimally invasive and cost-effective therapies for oncological and non-oncological situations, declares the sale of 10 Transdermal Infusion Programs to Hair Enhancement Facilities (HEC), a rapidly-growing chain of Texas-based hair loss therapy facilities. The Programs shall be used to non-invasively ship U.SK Beneath Pores and skin’s hair-health serum Pores and skin Savers Hair.  U.SK Beneath Pores and skin is a subsidiary of privately-held EMS Pharma, the most important pharmaceutical firm in Brazil and itself a subsidiary of Grupo NC, one among Brazil’s largest conglomerates.

Sensus will ship two Programs throughout the third quarter of 2022 and the remaining Programs throughout the fourth quarter.

“The mix of the hair-health serum from U.SK Beneath Pores and skin and the state-of-the-art Sensus TransDermal Infusion System ensures that serum is delivered painlessly and shortly deep into the hair follicle,” commented Paul Herchman, chief govt officer of Hair Enhancement Facilities. “Whereas HEC executives have greater than 35 years of expertise in introducing new medical applied sciences into the worldwide medical market, we depend on a scientific advisory board of main physicians to guage and in the end advocate the applied sciences we embody in our hair enhancement product providing. I converse for all of us after I say we’re very excited to introduce this selection for our prospects.”

Andre Freund, chief govt officer of U.SK Beneath Pores and skin USA, stated, “The Sensus TransDermal Infusion System is a Class II FDA-cleared biophysical different to infuse excessive molecular weight modalities into the dermis for medical and aesthetic functions with out needles, ache or downtime. When paired with U.SK Beneath Pores and skin’s focused Pores and skin Saver ampoules, physicians and aesthetics professionals are in a position to supercharge the therapies they’re already performing, enhancing outcomes and rising affected person satisfaction in an inexpensive, easy-to-use therapy. The gadget passes a painless microcurrent by means of the pores and skin, permitting the Pores and skin Savers to penetrate the intercellular water channels with out compromising the pores and skin or the answer. TransDermal Infusion can help molecules as much as 2 million Daltons into the pores and skin for elevated bioavailability and a distinction in therapy outcomes sufferers can see shortly.”

“I’m impressed with HEC’s progress, increasing from two clinics to 9 already to date 12 months thus far, with expectations for extra clinics over the approaching months,” stated Joe Sardano, chairman and chief govt officer of Sensus Healthcare. “We’re delighted to assist their future clinic progress with our TransDermal Infusion System to ship U.SK Beneath Pores and skin’s hair-health serum.  Hair progress renewal is a crucial indication because it impacts about 50 million American males and 30 million American ladies with male- or female-pattern baldness, in accordance with the Cleveland Clinic.”

“As well as, our System can painlessly supply a mess of medicine for a lot of totally different medical makes use of, similar to hyperhidrosis, in addition to different aesthetic purposes,” Mr. Sardano added.  “Anytime you’ll be able to get rid of ache from a process, the sufferers and their docs achieve a lot from the applying,” continued Mr. Sardano.

In regards to the TransDermal Infusion System

The TransDermal Infusion System is FDA-cleared to be used on any a part of the physique presently handled with needle injections. This allows numerous fillers and different injectables to be administered with out ache and with out affected person downtime.  Quicker than conventional iontophoresis, the TransDermal Infusion System permits supply of medicine which might be in any other case not in a position to be absorbed together with Botox®, hyaluronic acid, lidocaine, collagen and others sometimes utilized in aesthetic procedures. 

About Hair Enhancement Facilities

Hair Enhancement Facilities was based on the premise that hair loss is a treatable medical situation. HEC believes its medically supervised scientific hair progress therapies and hair transplant procedures are the best-in-class minimally invasive options and choices to deal with hair loss in women and men of all ages. Hair Enhancement Facilities use solely FDA-cleared gadgets and collaborates with revered, nationwide and native physicians to supply breakthrough therapies to their sufferers. The brand new line of medical grade hair regrowth merchandise branded as Get Hair are designed to reinforce the outcomes of its laser and transdermal infusion therapies.

Hair Enhancement Facilities has grown this 12 months from a single location in Southlake, Texas one 12 months in the past to 9 areas, and extra to return, offering service to sufferers throughout the Dallas/Ft. Value metroplex.  For extra data please go to www.hec-usa.com

About U.SK Beneath Pores and skin

U.SK Beneath Pores and skin is a premium dermocosmetics model that mixes science and effectiveness with sophistication and luxurious. Based in 2015, Beneath Pores and skin brings a brand new idea to the dermocosmetic market: SCIENCE BEHIND THE BEAUTY. Our merchandise carry the signature of Pores and skin Care Excessive Efficiency and had been developed with the tutelage of probably the most famend dermatologists, together with the experience of the Italian analysis and growth laboratory Monteresearch®, based mostly in Milan. Beneath Pores and skin combines progressive options for all pores and skin varieties together with the most recent scientific discoveries to make sure probably the most environment friendly merchandise with confirmed outcomes.

The mission of Beneath Pores and skin is to introduce progressive, high-performance merchandise and know-how to dermatologists by means of worldwide science and design, allied with luxurious sensory experiences to supply enhanced well being, magnificence and life-style to our customers.  Owned by the Brazilian firm Grupo NC, Beneath Pores and skin is a part of one of many world’s largest pharmaceutical firms, EMS Pharma.  For extra data, please go to www.underskin.com.

About Sensus Healthcare

Sensus Healthcare, Inc. is a medical gadget firm specializing in extremely efficient, non-invasive, minimally-invasive and cost-effective therapies for each oncological and non-oncological situations. Sensus gives its proprietary low-energy X-ray know-how often known as superficial radiation remedy (SRT), which is the fruits of greater than a decade of analysis and growth, to deal with non-melanoma pores and skin cancers and keloids with its SRT-100, SRT-100+ and SRT-100 Imaginative and prescient methods. With its portfolio of progressive medical gadget merchandise, together with aesthetic lasers and its needleless TransDermal Infusion System, Sensus supplies revolutionary therapy choices to reinforce the standard of lifetime of sufferers world wide.  For extra data, go to www.sensushealthcare.com.

Ahead-Wanting Statements

This press launch contains statements which might be, or could also be deemed, ”forward-looking statements.” In some circumstances, these statements may be recognized by way of forward-looking terminology similar to “believes,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “could,” “might,” “would possibly,” “will,” “ought to,” “roughly,” “potential” or damaging or different variations of these phrases or comparable terminology, though not all forward-looking statements comprise these phrases.

Ahead-looking statements contain dangers and uncertainties as a result of they relate to occasions, developments, and circumstances referring to Sensus, our business, and/or basic financial or different situations which will or could not happen sooner or later or could happen on longer or shorter timelines or to a larger or lesser diploma than anticipated. Though we imagine that we’ve an inexpensive foundation for every forward-looking assertion contained on this press launch, forward-looking statements will not be ensures of future efficiency, and our precise outcomes of operations, monetary situation and liquidity, and the event of the business during which we function could differ materially from the ahead trying statements contained on this press launch, on account of the next components, amongst others: the continuation and severity of the COVID-19 pandemic, together with its affect on gross sales and advertising and marketing; our capability to realize profitability; our capability to acquire and keep the mental property wanted to adequately shield our merchandise, and our capability to keep away from infringing or in any other case violating the mental property rights of third events; the extent and availability of presidency and/or third occasion payor reimbursement for scientific procedures utilizing our merchandise, and the willingness of healthcare suppliers to buy our merchandise if the extent of reimbursement declines; the regulatory necessities relevant to us and our opponents; our capability to effectively handle our manufacturing processes and prices; the dangers arising from our worldwide operations; laws, regulation, or different governmental motion that impacts our merchandise, taxes, worldwide commerce regulation, or different features of our enterprise; focus of our prospects within the U.S. and China, together with the focus of gross sales to 1 explicit buyer within the U.S.; and different dangers described every now and then in our filings with the Securities and Change Fee, together with our Annual Report on Type 10-Okay and Quarterly Studies on Type 10-Q.

As well as, even when future occasions, developments, and circumstances are per the forward-looking statements contained on this press launch, they might not be predictive of outcomes or developments in future durations. Any forward-looking statements that we make on this press launch converse solely as of the date of such assertion, and we undertake no obligation to replace such statements to replicate occasions or circumstances after the date of this press launch, besides as could also be required by relevant legislation. You need to learn rigorously our “Introductory Word Concerning Ahead-Wanting Data” and the components described within the “Threat Elements” part of our periodic reviews filed with the Securities and Change Fee to higher perceive the dangers and uncertainties inherent in our enterprise.

Contact:

LHA Investor Relations

Kim Sutton Golodetz

212-838-3777

kgolodetz@lhai.com

#   #   #